Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections?

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 3, 2014, Pages 453-456

  De Vries, M G ^a   Ekkelenkamp, M B ^b   Peters, E J G ^c  

^a GELRE HOSPITALS   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ciprofloxacin; Clindamycin; Diabetes mellitus; Foot; Infection

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; FLUCLOXACILLIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DIABETIC FOOT; DIABETIC FOOT INFECTION; DISEASE SEVERITY; FEMALE; FOOT AMPUTATION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; ICD-9; LEG ULCER; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MIXED INFECTION; NETHERLANDS; NONHUMAN; ORTHOPEDIC FIXATION DEVICE; PRIORITY JOURNAL; PROSTHESIS INFECTION; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; ULCER HEALING; WOUND ASSESSMENT; WOUND INFECTION;

AGED; AMPUTATION; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CIPROFLOXACIN; CLINDAMYCIN; COHORT STUDIES; DIABETIC FOOT; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; WOUND HEALING;

EID: 84896714861     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1977-7     Document Type: Article

References (17)

1. Adler AI, Boyko EJ, Ahroni JH et al (1999) Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 22(7):1029-1035
2. Citron DM, Goldstein EJ, Merriam CV et al (2007) Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 45(9):2819-2828
3. El-Tahawy AT (2000) Bacteriology of diabetic foot. Saudi Med J 21(4):344-347
4. Abdulrazak A, Bitar ZI, Al-Shamali AA et al (2005) Bacteriological study of diabetic foot infections. J Diabetes Complications 19(3):138-141
5. Lipsky BA, Berendt AR, Cornia PB et al (2012) 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54(12):e132-e173
6. Lipsky BA, Peters EJ, Senneville E et al (2012) Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev 28(Suppl 1):163-178
7. Dutch Working Party on Antibiotic Policy. Therapy advice diabetic foot [Stichting Werkgroep Antibiotica Beleid. Therapieadvies diabetische voet]
8. Armstrong DG, Lavery LA, Vela SA et al (1998) Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med 158(3):289-292
9. Bakker K, Apelqvist J, Schaper NC et al (2012) Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 28(Suppl 1):225-231
10. Berendt AR, Peters EJ, Bakker K et al (2008) Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 24(Suppl 1):S145-S161
11. Schaper NC (2004) Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res 20(Suppl 1):90-95
12. Senneville E, Melliez H, Beltrand E et al (2006) Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 42(1):57-62
13. Mutluoglu M, Uzun G, Turhan V et al (2012) How reliable are cultures of specimens from superficial swabs compared with those of deep tissue in patients with diabetic foot ulcers? J Diabetes Complications 26(3):225-229
14. Sotto A, Richard JL, Combescure C et al (2010) Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers. Diabetologia 53(10):2249-2255
15. Ramakant P, Verma AK, Misra R et al (2011) Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia 54(1):58-64
16. Lipsky BA, Itani K, Norden C (2004) Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin Infect Dis 38(1):17-24
17. Buter CC, Mouton JW, Klaassen CH et al (2010) Prevalence and molecular mechanism of macrolide resistance in beta-haemolytic streptococci in The Netherlands. Int J Antimicrob Agents 35(6):590-592